[1] |
Jiang Y, Huang S, Fu X, et al. Epidemiology of chronic cutaneous wounds in China[J]. Wound Repair Regen, 2011, 19(2): 181-188.
|
[2] |
王爱红,赵湜,李强,等. 糖尿病足患者医疗费用分析[J]. 中华内科杂志,2007, 46(6): 471-474.
|
[3] |
李津凯,阚世廉,张秀军,等. 前列地尔联合胰激肽原酶治疗早期糖尿病足的疗效观察[J]. 国际内分泌代谢杂志,2016, 36(2): 121-123.
|
[4] |
Ramasamy R, Yan SF, Schmidt AM. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications[J]. Ann N Y Acad Sci, 2011, 1243: 88-102.
|
[5] |
Maree A, Peer G, Iaina A, et al. Nitric oxide instreptozotocin-induced diabetes mellitus in rats[J]. Clin Sci (Lond), 1996, 90(5): 379-384.
|
[6] |
Senthil D, Choudhury GG, Mclaurin C, et al. Vascular endothelial growth factor induces protein synthesis in renal epithelialcells:a potential role in diabetic nephropathy[J]. Kidney Int, 2003, 64(2): 468-479.
|
[7] |
刘思容,荣新洲,樊桂成,等. 糖尿病足患者坏死组织与血液及尿液中多胺含量测定与相关分析[J]. 中华烧伤杂志,2013, 29(6): 526-530.
|
[8] |
陈健霞,荣新洲,樊桂成,等. 不同浓度腐胺对人脐静脉内皮细胞生物学行为的影响[J]. 中华烧伤杂志,2015, 31(6): 446-450.
|
[9] |
Falanga V. Wound healing and its impairment in the diabetic foot[J]. Lancet, 2005, 366(9498): 1736-1743.
|
[10] |
孟庆元,林炜栋,陈向芳. AGE-RAGE系统与糖尿病足综合征的发病机制及治疗进展[J]. 药学服务与研究,2009, 9(2): 118-121.
|
[11] |
Teissier T, Boulanger é. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging[J]. Biogerontology, 2019, 20(3): 279-301.
|
[12] |
Yetik-Anacak G, Catravas JD. Nitricoxide and the endothelium:history and impacton cardiovascular disease[J], Vasc Pharmacol, 2006, 45(5): 268-276.
|
[13] |
Amemiya T, Sasamura H, Mifune M, et al. Vascular endothelial gowthfactor activates MAP kinase and enhances collagen synthesis in human mesanginal cells[J]. Kidney Int, 1999, 56(6): 2055-2063.
|
[14] |
Malone-Povolny MJ, Maloney SE, Schoenfisch MH. Nitric Oxide Therapy for Diabetic Wound Healing[J]. Adv Healthc Mater, 2018, 8(12): e1801210.
|
[15] |
Edmonds ME, Bodansky HJ, Boulton AJM. Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 study[J]. Wound Repair Regen, 2018, 26(2): 228-237.
|
[16] |
Vassallo IM, Formosa C. Comparing Calcium Alginate Dressings to Vacuum-assisted Closure: A Clinical Trial[J]. Wounds, 2015, 27(7): 180-190.
|
[17] |
Borys S, Hohendorff J, Koblik T, et al. Negative- pressure wound therapy for management of chronic neuropathic noninfected diabeticfoot ulcerations -short-term efficacyand long-term outcomes[J]. Endocrine, 2018, 62(3): 611-616.
|
[18] |
Karam RA, Rezk NA, Abdel Rahman TM, et al. Effect of negative pressure wound therapy on molecular markers in diabetic foot ulcers[J]. Gene, 2018, 667: 56-61.
|
[19] |
Li X. The association between MCP-1, VEGF polymorphisms and their serum levels in patients with diabetic foot ulcer[J]. Medicine (Baltimore), 2018, 97(24): e10959.
|
[20] |
王齐,曹晓赞,朱冠娅,等. 外源性阻断RAGE效应对糖尿病小鼠创面中巨噬细胞浸润的影响[J]. 上海交通大学学报(医学版), 2017, 37(12): 1588-1593.
|